. Author manuscript; available in PMC: 2014 Mar 1.

Published in final edited form as: J Med Virol. 2012 Dec 21;85(3):524–529. doi: 10.1002/jmv.23498

Table 1.

Sequences of Target Peptides Used in Anti-EBV ELISAs

Peptide EBNA (BKRF1):
“PPRRPPPGRRPFFHPVGEADYFEYHQEDGEPDVPPGAIEQGPADDPGEGPSTGPRG”^a

Peptide VCA-p18 (BFRF3):
“STAVAQSATPSVSSSISSLRAATSGATAAAAVDTGSGGGGQPHDTAPRGARKKQ”^a

Peptide EAd-p47 (BMRF1):
“TVSPSPSPPPPPRTPTWESHSSNTALERPLAVQLARKRTSSEARQ”^a

Peptide EAd-p138 (BALF2):
“KSVRVPLYDKEVFPEGVPQLRQFYNSDLSLGIDAEGKL”
+“KTGTNGPGNYAVEHLVYAASFSPNLLARYAYYLQF”^a

Peptide Zebra (BZLF1):
“MMDPNSTSEDVKFTPDPYQVPFVQAFDQATRVYQDLGGPSQAPLPCV”

patent protected and proprietary to Cyto-Barr B.V. (Zuidhorn, Netherlands)